The global Gene Delivery System Market, valued at US$ 5.4 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2031, reaching US$ 10.0 billion by 2031. Gene delivery systems, including viral (e.g., AAV, lentivirus) and non-viral vectors (e.g., liposomes, nanoparticles), enable targeted gene therapy for rare genetic disorders, cancers, and chronic...